We have data on 1,174 companies that use Illumina DNA Sequencing. The companies using Illumina DNA Sequencing are most often found in United States and in the Higher Education industry. Illumina DNA Sequencing is most often used by companies with 1000-5000 employees and >1000M dollars in revenue. Our data for Illumina DNA Sequencing usage goes back as far as 4 years and 7 months.
|Caris Life Sciences, Inc.||carislifesciences.com||United States||200M-1000M||1000-5000|
|Delaware State University||desu.edu||United States||100M-200M||1000-5000|
|Oberlin College||oberlin.edu||United States||200M-1000M||1000-5000|
|CYSTIC FIBROSIS FOUNDATION||cff.org||United States||100M-200M||500-1000|
|Ambry Genetics Corp.||ambrygen.com||United States||100M-200M||500-1000|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.1%. Other major and competing products in this category include:
For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain.
Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (24%), Hospital & Health Care (19%), Biotechnology (9%), Education Management (7%), Research (6%) and Pharmaceuticals (5%) are the largest segments.
58% of Illumina DNA Sequencing customers are in United States and 8% are in United Kingdom.